Therefore, we need to further explore the mechanism by which overexpressed HIF-1α under hypoxic conditions regulates changes in lncRNA levels in tumor cells and how HIF-1α plays a role in promoting EMT, leading to tumor development and poor prognosis, and ultimately finding targets for anticancer therapy. This evidence concerns the gene HIF1A and neoplasm.